Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lietao Li"'
Autor:
Markus Kellner, Julia Hörmann, Susanne Fackler, Yuanyu Hu, Tielin Zhou, Lin Lu, Ibrahim Ilik, Tugce Aktas, Regina Feederle, Stefanie M. Hauck, Olivier Gires, Kathrin Gärtner, Lietao Li, Reinhard Zeidler
Publikováno v:
Cells, Vol 13, Iss 18, p 1563 (2024)
The membrane composition of extracellular vesicles (EVs) largely reflects that of the plasma membrane of the cell of origin. We therefore hypothesized that EVs could be used for immunizations to generate monoclonal antibodies against well-known tumor
Externí odkaz:
https://doaj.org/article/d3cd5443d9214ae6b3b43c2407cb6346
Publikováno v:
Diseases, Vol 4, Iss 1, p 10 (2016)
Cancer immunotherapy using a patient’s own T cells redirected to recognize and kill tumor cells has achieved promising results in metastatic melanoma and leukemia. This technique involves harnessing a patient’s T cells and then delivering a gene
Externí odkaz:
https://doaj.org/article/035e401c69f34f40a2043462412debcb
Autor:
Fang Liu, Rongliang Hu, Yi Zhang, Yuan Liu, Hui Shao, Hua Liu, Shoufeng Zhang, Lietao Li, Haixiang Lin
Publikováno v:
Antiviral Research. 135:56-61
Most reported vaccination failures among rabies-exposed patients were due to fail to timely co-administer rabies immunoglobulin (RIG). Considering that such protection failure might be caused by low antigen titers in the vaccine, scientists improved
Autor:
Yuan Liu, Yi Zhang, Wei Li, Haixiang Lin, Fang Liu, Rongliang Hu, Shu Xu, Yuchi Hu, Shoufeng Zhang, Hui Shao, Lietao Li, Liliang Wang, Jinyan Zhao
Publikováno v:
Virology. 489:165-172
Vaccination alone is not sufficiently effective to protect human from post-exposure rabies virus infection due to delayed generation of rabies virus neutralizing antibodies and weak cellular immunity. Therefore, it is vital to develop safer and more
Publikováno v:
Archives of virology. 158(4)
Our study presents a first investigation of the effect of the adjuvant PIKA on dengue virus (DENV) replication. PIKA pretreatment decreased the levels of DENV serotype 2 (DENV2) mRNA, protein and viral particles in the hepatoma cell line HepG2. Treat
Autor:
Erxia, Shen, Li, Li, Lietao, Li, Lianqiang, Feng, Lin, Lu, Ziliang, Yao, Haixiang, Lin, Changyou, Wu
Publikováno v:
Cellularmolecular immunology. 4(2)
An adjuvant is usually used to enhance the immune response induced by vaccines. The choice of adjuvant or immune enhancer determines the effectiveness of the immune response. Currently, aluminium (Alum, a generic term for salts of aluminium) is the o